University of Crete (UOC)
Μελέτη της αναγκαιότητας της προληπτικής αντιμικροβιακής αγωγής πληθυσμών υψηλού κινδύνου για ανάπτυξη λοιμώξεων
Abstract
dc:descriptionCandidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients The objective of the case-control study was to determine the risk factors for development of candidemia in patients requiring intensive care unit (ICU) treatment for more than 48h and to study the possible role of antifungal prophylaxis in the development and outcome of candidemia. Patients admitted to the medical-surgical ICU who developed candidemia after at least 48h were matched to a control group of ICU patients according to five variables: length of ICU stay until development of candidemia, age, admission department (medical, surgical, and ICU), admission year and sex. Forty-five patients with candidemia were enrolled in the study (incidence of candidemia 0.6 cases/1000 patient-days. Candida albicans was the most commonly isolated yeast followed by C. tropicalis. The risk factors associated with development of candidemia were Candida colonization, duration of mechanical ventilation, gastrointestinal (GIT) surgery, total parenteral nutrition, absolute lymphocyte count <1000/μl at the day of the positive blood culture, and diabetes mellitus. In the regression analysis Candida colonization and GIT surgery were independently associated with candidemia. Prophylactic administration of antifungals was not associated with better outcomes or non-albicans candidemia. ICU and total in-hospital mortality were 40% and 66.7%, respectively. Candidemia related mortality was 20%. Candidemia treatment failure was the only variable associated with in-hospital mortality (p=0.008). Candidemia in the ICU develops mainly in critically ill patients with multiple organ failure and end-stage disease and it is associated with increased morbidity and mortality. Patient populations that may benefit from preventive measures, including the use of antifungal prophylaxis, should be further studied. ....................
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vardakas, Konstantinos
- Βαρδάκας, Κωνσταντίνος
Subjects
dc:subject × 20- Μυκητιάσεις
- Κάντιντα
- Προφύλαξη
- Μονάδα εντατικής θεραπείας ( ΜΕΘ )
- Αιματολογία
- Μεταμόσχευση μυελού οστών
- Φλουκοναζόλη
- Ιτρακοναζόλη
- Fungal infections
- Candida
- Prevention
- Intensive care units (ICU)
- Hematology
- Bone marrow transplantation
- Fluconazole
- Itraconazole
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24879